首页 | 本学科首页   官方微博 | 高级检索  
检索        

原发性食管小细胞癌16例临床分析
引用本文:寇卫政,路平,牛红蕊,苗战会.原发性食管小细胞癌16例临床分析[J].医学信息,2008,21(7).
作者姓名:寇卫政  路平  牛红蕊  苗战会
作者单位:新乡医学院第一附属医院肿瘤科,河南卫辉453100
摘    要:目的探讨原发性食管小细胞癌的临床特点、治疗及预后。方法回顾分析16例原发性食管小细胞癌患者的临床资料。结果1年总生存率为56.2%,2年总生存率25.0%,3年总生存率12.5%。中位生存期15.7个月。结论对于原发性食管小细胞癌应采用以化疗占主要地位的综合治疗,局限期以手术联合化疗,广泛期以放疗联合化疗为宜。

关 键 词:食管  小细胞癌  综合治疗  预后

Clinical analysis of 16 cases with primary esophageal small cell carcinoma
KOU Wei-zheng,LU Ping,NIU Hong-rui,et al.Clinical analysis of 16 cases with primary esophageal small cell carcinoma[J].Medical Information,2008,21(7).
Authors:KOU Wei-zheng  LU Ping  NIU Hong-rui  
Institution:KOU Wei-zheng,LU Ping,NIU Hong-rui,et al(Department of Medical Oncology,the First Affiliated Hospital of Xinxiang Medical University,Weihui 453100,China)
Abstract:Objective To investigate the clinical characteristics,management and prognosis of primary small cell esophageal carcinoma(SCEC).Methods The clinical data of sixteen cases with SCEC were analyzed retrospectively.Results The 1 year,2 and 3 year survival rates were 56.2%,25.0% and 12.5% respectively,and the median survival time of all the cases was 15.7 months.Conclusions Cases with SCEC should be managed by chemotherapy-based combination therapy.Surgery combination chemotherapy in limited stage and inextensiv...
Keywords:esophageal  small cell carcinoma  combined modality therapy  prognosis  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号